Baxter Healthcare Corporation: Daptomycin, In 0.9% Sodium Chloride Injection, 500 Mg Per
Daptomycin Recall Summary Baxter Healthcare Corporation is recalling Daptomycin in 0.9% Sodium Chloride Injection (500 mg per 50 mL) nationwide due to manufacturing deviations that don't meet quality standards. The recalled product was distributed across all U.S. states, Puerto Rico, and Chile. This is a Class II recall, meaning the product could cause serious health problems or failure of an essential medical function.
- Recalling firm
- Baxter Healthcare Corporation
- Product
- Daptomycin, in 0.9% Sodium Chloride Injection, 500 mg per 50 mL (10 mg/mL), 500 mg total, in 50 mL Single Dose Container (24 bags/carton), Rx only, Sterile Nonpyrogenic, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-0714-24.
- Reason
- CGMP Deviations
- Classification
- Class II
- Category
- drug recall
- Country
- United States
- Agency
- U.S. Food and Drug Administration
- Recall date
- 2026-08-06
- Status
- Ongoing
- Areas affected
- AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...
- Distribution
- US Nationwide; Puerto Rico; and Chile.
Official recall notice from U.S. Food and Drug Administration
Recall details on Nibble Recalls: https://trynibble.app/recalls/01ce5d5d-1b39-4995-8734-2210cd748562